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Abstract
Background: Coxiella burnetii is an intracellular bacterial pathogen that causes acute and chronic disease in
humans. Bacterial replication occurs within enlarged parasitophorous vacuoles (PV) of eukaryotic cells, the
biogenesis and maintenance of which is dependent on C. burnetii protein synthesis. These observations suggest
that C. burnetii actively subverts host cell processes, however little is known about the cellular biology mechanisms
manipulated by the pathogen during infection. Here, we examined host cell gene expression changes specifically
induced by C. burnetii proteins during infection.
Results: We have identified 36 host cell genes that are specifically regulated when de novo C. burnetii protein
synthesis occurs during infection using comparative microarray analysis. Two parallel sets of infected and
uninfected THP-1 cells were grown for 48 h followed by the addition of chloramphenicol (CAM) to 10 μg/ml in
one set. Total RNA was harvested at 72 hpi from all conditions, and microarrays performed using Phalanx Human
OneArray™ slides. A total of 784 (mock treated) and 901 (CAM treated) THP-1 genes were up or down regulated
≥2 fold in the C. burnetii infected vs. uninfected cell sets, respectively. Comparisons between the complementary
data sets (using >0 fold), eliminated the common gene expression changes. A stringent comparison (≥2 fold)
between the separate microarrays revealed 36 host cell genes modulated by C. burnetii protein synthesis.
Ontological analysis of these genes identified the innate immune response, cell death and proliferation, vesicle
trafficking and development, lipid homeostasis, and cytoskeletal organization as predominant cellular functions
modulated by C. burnetii protein synthesis.
Conclusions: Collectively, these data indicate that C. burnetii proteins actively regulate the expression of specific
host cell genes and pathways. This is in addition to host cell genes that respond to the presence of the pathogen
whether or not it is actively synthesizing proteins. These findings indicate that C. burnetii modulates the host cell
gene expression to avoid the immune response, preserve the host cell from death, and direct the development
and maintenance of a replicative PV by controlling vesicle formation and trafficking within the host cell during
infection.
Background
Coxiella burnetii is a Gram-negative, pleomorphic, intra-
cellular bacterial pathogen with a worldwide distribution
[1,2]. Virulent strains cause human Q-fever, which is
usually marked by an acute self-limiting flu-like illness.
Persistent infections usually progress into chronic dis-
ease [1,3,4]. Human infection occurs via inhalation of
aerosols contaminated with C. burnetii. The small cell
variant (SCV) form of the bacterium, which are metabo-
lically inactive and environmentally stable, are believed
to be responsible for most environmentally acquired
infections. SCVs passively ingested by mononuclear pha-
gocytes are trafficked along the endocytic pathway and
associate with a variety of endocytic and autophagic
markers before ultimately residing within a parasito-
phorous vacoule (PV) with characteristics of a secondary
lysosome [1-3]. Here, they undergo a replicative lag
phase of 1-2 days while differentiating into the
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they are not environmentally stable, LCVs are infectious
in laboratory settings and pose a risk of causing disease.
After differentiation, LCVs then undergo exponential
replication for ~4 days (log phase) before beginning an
asynchronous conversion back to SCVs at ~6 days post
infection (PI) [5,6]. LCV replication is accompanied by a
remarkable expansion of the PV, which eventually occu-
pies the majority of the host cell [2,7].
Intracellular bacterial pathogens are known to operate
by targeting and subverting vital intracellular pathways
of the host [8,9]. Bacterial proteins are a key factor in
this subversion of host cell molecular mechanisms
[2,9-11]. Biogenesis and maintenance of the PV, interac-
tion with the autophagic pathway, and inhibition of host
cell apoptosis are all dependent on C. burnetii protein
synthesis [2,7,12-14]. After ingestion by a host cell, C.
burnetii PV maturation experiences a delay when com-
pared to vacuoles carrying latex beads or dead C. burne-
tii [7,15]. This delay in phagolysosomal maturation
requires ongoing bacterial protein synthesis [7]. C. bur-
netii protein synthesis is also required for the fusogeni-
city of C. burnetii containing vacuoles, PV fusion with
host vesicles, and in the maintenance of a spacious PV
(SPV) during logarithmic bacterial growth [7,15]. Transi-
ent interruption of bacterial protein synthesis results in
cessation of SPV-specific vesicle trafficking and SPV col-
lapse [7,15]. The C. burnetii PV is thought to interact
with the autophagic pathway as a means to provide
metabolites to the bacterium. This interaction is also a
pathogen driven activity [16]. Additionally, an examina-
tion of the PV has revealed increased amounts of cho-
lesterol in the membranes [12]. Interestingly, C. burnetii
infected cells have been observed to dramatically
increase cholesterol production. During log growth, the
PV expands and is accompanied by increased transcrip-
tion of host genes involved in both cholesterol uptake
(e.g. LDL receptor) and biosynthesis (e.g. lanosterol
synthase) [2,12].
Recently, the function of the host cell apoptotic path-
way has been shown to be altered during C. burnetii
infection. C. burnetii was shown to actively inhibit apop-
tosis in macrophages exposed to inducers of both the
extrinsic and intrinsic apoptotic pathways in a bacterial
protein synthesis dependant manner [14]. This antiapop-
totic activity causes a marked reduction in activated cas-
pase-3, caspase-9, and poly-ADP (ribose) polymerase
(PARP) processing. Other data indicate that C. burnetii
mediates the synthesis of host anti-apoptotic proteins
A1/Bfl-1 and c-IAP2, which might directly or indirectly
prevent release of cytochrome C from mitochondria,
interfering with the intrinsic cell death pathway during
infection [17]. Moreover, activation of the pro-survival
host kinases Akt and Erk1/2 by C. burnetii was shown
to protect infected host cells from apoptosis [18].
Despite the information on processes that appear to be
affected by C. burnetii proteins, little is known about
the host molecular mechanisms being targeted through-
out the course of infection.
A common theme among bacterial pathogens, includ-
ing C. burnetii, is the ability to secrete effector proteins
into the host cell as part of their pathogenic strategy
[9,10]. The possession of a type IV secretion system
(T4SS) by C. burnetii suggests that effector proteins
might be delivered to the host cell via this machinery
[2,10,19,20]. As the genetic manipulation of C. burnetii
is in its infancy, indirect approaches such as bioinfor-
matic screens have been useful in predicting putative
T4SS substrates. Recent data indicate that C. burnetii
encodes multiple proteins with eukaryotic-like domains,
including ankyrin repeat binding domains (Anks), tetra-
tricopeptide repeats (TPRs), coiled-coil domains (CCDs),
leucine-rich repeats (LRRs), GTPase domains, ubiquiti-
nation-related motifs, and multiple kinases and phos-
phatases [2,21,22]. Studies have shown that a number of
the C. burnetii encoded Ank proteins are secreted into
the host cell cytoplasm through the Legionella pneumo-
phila T4SS [11,19,22]. Three of these proteins associate
with the PV membrane, microtubules, and mitochon-
dria, respectively, when expressed ectopically within
eukaryotic cells [19].
These observations suggest that C. burnetii proteins
directly interact and exploit mammalian intracellular
pathways leading to the establishment and prolongation
of the replicative niche. Here, we use the avirulent C.
burnetii Nine Mile phase II (NMII) strain and the tran-
sient inhibition of bacterial protein synthesis as a means
to elucidate host molecular mechanisms that are being
actively targeted by C. burnetii during infection. While
the C. burnetii NMII strain does not cause Q fever, it is
a recognized model for the analysis of molecular host
cell-pathogen interactions. Recent studies clearly
demonstrate that the virulent Nine Mile phase I (NMI)
and avirulent NMII strains grow at similar rates and are
trafficked to similar intracellular vacuoles during infec-
tion of cultured monocytic cells (THP-1) as well as pri-
mary monocytes/macrophages [23,24], making NMII an
excellent model for molecular studies of this unusual
pathogen. In the current study, we have analyzed C.
burnetii NMII protein induced gene expression changes
in infected THP-1 cells. Using microarray technology
we have examined the global transcriptional response of
THP-1 cells during C. burnetii infection by transiently
inhibiting (bacteriostatically) bacterial protein synthesis
during the logarithmic phase of infection and comparing
this to normal (mock treated) infections ran in parallel.
Using stringent comparative microarray data analyses,
we have discovered 36 previously unidentified host
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burnetii proteins. Gene ontology analysis on these data
was performed to define the host cell processes being
targeted by this bacterium during infection.
Methods
C. burnetii and cell culture growth and infection
C. burnetii Nine Mile phase II was grown in Vero cells
(CCL-81; ATCC, Manassas, VA) and purified as pre-
viously described [20]. Non-adherent THP-1 human
monocytic leukemia cells (TIB-202; ATCC) were propa-
gated in RPMI 1640 medium (Gibco, Carlsbad, CA) sup-
plemented with 1 mM sodium pyruvate, and 10% fetal
bovine serum (FBS) at 37°C in 5% CO2. THP-1 cells
between passages 6-10 were used in all experiments
[14]. Briefly, purified C. burnetii NMII SCVs at a gen-
ome equivalent MOI of 15 were used to establish a syn-
chronous infection. To ensure close host cell-bacteria
contact, C. burnetii SCVs diluted in RPMI 1640 contain-
ing 10% FBS were incubated in 25 cm
2 tissue culture
flasks (Becton Dickinson, Franklin Lakes, NJ) with 5 ×
10
6 THP-1 cells in a total volume of 2.5 ml. Incubations
were performed at 37°C in an atmosphere of 5% CO2
for 4 hours. Cells were pelleted by centrifugation at 600
g for 5 minutes, washed with fresh media and pelleted
again. Cell pellets were then re-suspended in 5 ml of
fresh media (final concentration = 10
6 cells/ml) and
transferred to new 25 cm
2 tissue culture flasks (this
represents T = 0). Cells were pelleted again at 48 hours
post infection (hpi) and re-suspended in fresh media
with or without the bacterial protein synthesis inhibitor
chloramphenicol (CAM, a final concentration of 10 μg/
ml), as needed. Cells were then incubated for an addi-
tional 24 hours for either total RNA harvest or micro-
s c o p ya n a l y s i s( s e eF i g u r e1 ) .I n f e c t e da n du n i n f e c t e d
cells were handled identically and a total of three experi-
ments (N = 3) were carried out for microarray analysis.
Comparative microarray design and analysis
In order to perform the microarray hybridizations, two
parallel infection and treatment protocols were
employed. A schematic of the comparative microarray
experimental design highlighting the separate treatment
conditions is shown in Figure 1. Using this experimental
design, a comparison was made between the THP-1
transcriptional responses of (i) uninfected versus C. bur-
netii NMII infected and (ii) uninfected versus C. burne-
tii NMII infected THP-1 cells transiently treated with
bacteriostatic levels (10 μg / m l )o fC A M .B r i e f l y ,i n f e c -
tions were initiated and cultured in parallel with unin-
fected cells. At 48 hpi media containing CAM (10 μg/
ml) was added to one set of cells (uninfected and
infected THP-1 cells) and culturing was continued. The
other set of cells were mock treated with normal media.
Total RNA was isolated at 72 hpi from all conditions.
Microarrays were performed for both conditions and
the results were compared to define the host genes
modulated by de novo synthesized C. burnetii NMII pro-
teins. The 48-72 hpi time frame was used because (i) C.
burnetii would be in logarithmic growth [6] and, (ii)
previous studies have shown observable changes in PV
size within C. burnetii infected Vero cells when treated
overnight with 10 μg/ml of CAM at 48 hpi [7].
RNA extraction, microarray hybridization and data
analysis
Following the infection and treatment protocols (Figure 1),
total RNA was isolated using Tri-Reagent (Ambion,
Austin, TX) according to the manufacturer’s recommen-
dations. All RNA samples were DNase treated using RQ1
DNase (Promega, Madison, WI) and confirmed DNA free
by PCR. RNA integrity was assessed by electropherogram
using a 2100 Bioanalyzer (Agilent Technologies, Santa
Clara, California). Total RNA (500 ng) from each sample
was then amplified using an Epicentre® Biotechnologies
(Madison, WI) TargetAmp™ 1-Round AminoallylaRNA
Amplification Kit, yielding approximately 6-10 μg of ami-
noallyl-aRNA (AA-aRNA). Alexa Fluor® 555-GREEN (Invi-
trogen, Carslbad, CA) was used to label the uninfected
AA-aRNA, while Alexa Fluor® 647-RED (Invitrogen) was
used to label the AA-aRNA from the C. burnetii infected
cells. Labeled AA-aRNA (2 μg) with a dye incorporation
efficiency range of 18-34 picomol/microgram, were mixed
pair-wise and hybridized overnight to Human OneArray™
microarrays (Phalanx Biotech Group, Palo Alto, CA).
Human OneArrays contain 32,050 oligonucleotides; 30968
human genome probes and 1082 experimental control
probes formed as 60-mer sense-strand DNA elements.
Arrays were hybridized, washed, and dried rapidly accord-
ing to the manufacturer’s instructions. Six hybridizations
for each condition set (CAM and mock treated) were
performed with three biological and two technical repli-
cates. Signal intensity of the hybridized arrays were mea-
sured by ScanArray Express (PerkinElmer, Boston, MA,
USA) and the images were processed using GenePix Pro
version 4.0 (Axon, Union City, CA, USA). The processed
GenePix Pro 4.0 output was further analyzed using Loess-
Global intensity dependent normalization through the
GenePix Auto Processor (http://darwin.biochem.okstate.
edu/gpap3/) as previously described [25-27]. Normalized
ratio values for each data point were averaged across the
three biological replicates and two technical replicates.
Significant expression differences were defined as a
P-value < 0.05 and displayed as a fold change of ≥2f o l d
[28,29]. The microarray data were deposited at the NCBI
Gene Expression Omnibus (GEO) under the platform
accession number GPL6254 and the series number
GSE23665. The biological function of the identified genes
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Annotation, Visualization, and Integrated Discovery
(DAVID) v6.7 (http://david.abcc.ncifcrf.gov/) [30] as well
as by Ingenuity pathway analysis (Ingenuity® Systems,
http://www.ingenuity.com). This software identifies cano-
nical pathways within gene sets using significant associa-
tions (P < 0.05) calculated by Fisher’s exact test and also
by a ratio of the number of molecules from the experi-
mental data set that maps to the pathway, divided by the
total number of molecules that exists in that canonical
pathway.
Immunofluorescence microscopy
Non-adherent THP-1 cells (CAM and mock treated)
were analyzed by indirect immunofluorescent antibody
(IFA) microscopy. Briefly, 1 × 10
5 cells were cytocentri-
fuged onto poly-L-lysine coated slides for 2 minutes at
1000 rpm using a Shandon Cytospin® 4 Cytocentrifuge
(Thermo Scientific) [31]. The cytospun THP-1 cells
were air dried and immediately fixed using ice cold acet-
one for 30 seconds. The fixed preparations were then
washed with PBS and stained with a rabbit antibody
against whole killed C. burnetii NMII (primary antibody)
followed by a goat anti-rabbit IgG Alexa Fluor-488
(Molecular Probes, Eugene, OR) secondary antibody.
Host and bacterial DNA were also stained using
4’,6-diamidino-2-phenylindole (DAPI). Microscopy was
conducted using a Nikon Eclipse TE 2000-S microscope
with a Nikon DS FI1 camera and NIS-ELEMENTS F
3.00 software. IMAGEJ version 1.42n (Wayne Rasband,
NIH) was also used for image processing [20].
RT-qPCR analysis
RT-qPCR was performed using gene-specific primers
(shown in Additional file 1-Table S1.I), and the SYBR
Green Master Mix Kit (Applied Biosystems) on an Eppen-
dorf Mastercycler® ep realplex (Eppendorf, Hamberg, Ger-
many) following the manufacturer’s recommendations.
Briefly, first strand cDNA was synthesized using random
hexamers, 1 μg of total RNA, and the SuperScript III First-
Strand Synthesis System for RT-PCR (Invitrogen) as sug-
gested by the manufacturer. Oligonucleotide primers were
designed using Primer3Plus [32,33]. The primer efficiency
of each primer set was determined to be within the effi-
ciency window for the 2
-ΔΔCT relative fold calculation
method [34]. The human b-actin gene was used as the
reference gene. Paired T-Test was performed to identify
statistical differences between any two conditions. Differ-
ences were considered significant at a P < 0.05.
Results
SPV morphology within CAM treated C. burnetii infected
THP-1 cells
As the transient inhibition of C. burnetii protein synth-
esis within infected THP-1 cells using CAM is pivotal to
testing our hypothesis, we sought to confirm that
Figure 1 Diagram of the experimental design for comparative C. burnetii infected host-cell microarrays. The rows of the top panel are
untreated and rows of the bottom panel are treated with CAM (10 μg/ml) at 48 h hpi. Total RNA harvests are performed at 72 hpi for
subsequent microarray analysis.
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THP-1 cells after transient CAM treatment in a manner
consistent with that observed in other cell types [35].
Using phase contrast and IFA microscopy analysis, we
assessed the effect of bacteriostatic levels of CAM (10
μg/ml) on infected THP-1 cells during the log growth
phase of the C. burnetii infectious cycle in order to
coincide with subsequent microarray analysis. Robust
infections (≥90% infected cells) were produced using C.
burnetii NMII at a genome equivalent MOI of 15. Infec-
tions were either mock or CAM treated at 48 hours
post infection (hpi), and then compared at 72 hpi.
Figure 2 shows both phase contrast (Figure 2 top panel)
and IFA microscopy (Figure 2, middle and bottom
panels) images representative of the C. burnetii NMII
infection of THP-1 cells at 72 hpi. Multiple, large SPVs
can be seen in the mock treated THP-1 infections, while
smaller, dense PVs are observed in the CAM treated
infections. These results are in agreement with pub-
lished findings where transient CAM treatment resulted
in PV collapse in C. burnetii infected Vero cells [7]. Fig-
ure 2C-H shows a set of similarly treated infections
visualized by IFA microscopy. C. burnetii are visualized
in green (Figure 2, C and 2F) and cell nuclei are stained
in blue (Figure 2, D and 2G) and the images merged
(Figure 2, E and 2H). Comparing the mock and CAM
treated images (Figure 2, C and 2F), a noticeable
decrease in vacuole size and fluorescent intensity is
observed, indicating the collapse of the SPVs within the
CAM treated cells when compared to the large, SPVs
observed within the mock treated cells. Comparisons
of DNA samples harvested at 48 hpi (prior to CAM
treatment) and 72 hpi (after 24 h CAM treatment)
using qPCR determined that these samples had
similar C. burnetii genome equivalents, indicating
that the 10 μg/ml CAM concentration was acting
Figure 2 Phase contrast and fluorescent microscopy of C. burnetii infected THP-1 cells. All images are of C. burnetii infected THP-1 cells
72 hpi. Top Panel, Phase contrast microscopy. A, a mock treated infection. B, infection treated with 10 μg/ml CAM for the final 24 h. Arrows
indicate PVs. Middle Panel, IFA microscopy images of a mock treated infection. C, Alexa-488 staining of C. burnetii. D, DAPI staining. E, merge of
C and D. Bottom Panel, IFA microscopy images of an infection treated with 10 μg/ml CAM for the final 24 h. F, Alexa-488 staining of C. burnetii.
G, DAPI staining. H, merge of F and G. 400× magnification was used for all images.
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of CAM from infected cells after the 24 h transient
treatment resulted in the re-establishment of large, SPVs
within 48 h as observed by phase contrast microscopy
(data not shown). Together, these data indicate that 10
μg/ml of CAM is able to transiently arrest C. burnetii
protein synthesis in the THP-1 cell infection model.
Gene expression in mock and CAM treated infected vs.
uninfected THP-1 cells
As outlined in Figure 1, two whole genome RNA micro-
array analyses were performed resulting in the generation
of two separate global gene expression profiles. A total of
784 THP-1 genes (Additional file 1- Table S1.A) were
up- or down-regulated ≥2 fold in mock treated infected
vs. uninfected cells while a total of 901 THP-1 Additional
file 1 - Table S1.C) were up- or down-regulated ≥2f o l d
in CAM treated infected vs. uninfected cells. To identify
the host cell functions affected by C. burnetii infection
and proteins, these gene sets were annotated using
DAVID. A modified Fisher Exact P-Value test was used
to measure gene-enrichment in annotation terms. The
top biological function assignments for the mapped
genes (P < 0.05) expressed as the percentage of the 784
and 901 significant genes identified in the mock and
CAM treated microarrays, respectively, are shown in
Additional file 2- Figure S1. This figure aids in defining
the prominent cell functions affected by C. burnetii infec-
tion and proteins. Identified as affected cell functions
under both conditions are immune response, cell migra-
tion, regulation of programmed cell death, intracellular
signaling cascades, regulation of cell proliferation, and
cytoskeletal organization. Notable differences were
observed in the percentage of genes involved with each
of these functions under the mock treated and CAM
treated conditions, indicating a role for C. burnetii pro-
teins in changing gene expres s i o ni nt h e s ep a t h w a y s .
Other important host cell functions influenced under the
mock treated condition are protein phosphorylation, lipid
storage, gas homeostasis, cell-cell signaling, and cellular
ion homeostasis. While major cellular functions seen
affected only in CAM treated infected THP-1 cells are
cell cycle processes, cell activation, response to DNA
damage, lipid (sterol and cholesterol) transport, positive
regulation of cytokine biosynthetic processes, and regula-
tion of nitric oxide biosynthetic processes. Additional file
1- Tables S1.E and S1.F list the host genes associated
with each of these functions. Out of the 784 host genes
identified in the mock treated data set, 62 genes were not
assigned function by DAVID’s biological annotation cov-
erage. In the CAM treated infected vs. uninfected data
set, 102 out of the 901 host cell genes remained
unassigned.
To further define the prominent host cell pathways
affected by C. burnetii infection and proteins, an Ingenu-
ity pathway analysis (IPA) was performed on the 784 and
901 significant genes identified in the mock and CAM
treated microarrays, respectively. IPA identifies the top
canonical pathways represented in a group of genes.
Additional file 1-Tables S1.G and S1.H list the top cano-
nical pathways associated with the mRNA profiles of the
mock treated and CAM treated infected vs. uninfected
THP-1 cells, respectively. From the mock treated micro-
array set, 17 biological functions were influenced by
infection while 28 functions were significantly affected by
CAM treatment of infections (Additional file 1 Tables S1.
E and S1.F). Many of the biological functions identified
are the result of the molecular pathways identified by
IPA, with several innate immune response and stress
pathways implicated when C. burnetii protein synthesis is
arrested, again indicating a role for C. burnetii proteins
in managing the host cell response to infection.
Comparative analysis between mRNA profiles of untreated
and CAM treated uninfected/infected THP-1 cells
In order to identify the host cell genes differentially
expressed (≥2 fold) in response to de novo C. burnetii
protein synthesis, we compared the two separate mRNA
expression profiles. Microarray analysis of mock treated
(-CAM), uninfected vs. infected THP-1 cells using a
broad cut-off of >0 fold revealed a gene summary list of
2557 genes (P < 0.05) (Additional file 1- Table S1.B).
Within this data set are the 784 genes which changed
≥2 fold (S1.A), and was considered a significant change.
Using a >0 fold cut-off for the CAM treated (+CAM)
uninfected vs. infected THP-1 cells, a gene summary list
of 2584 genes were identified (Additional file 1 - Table
S1.D). The subset of 901 genes that changed signifi-
cantly (≥2 fold, S1.B) was within this large gene sum-
mary list. Figure 3 depicts a comparison of these two
sets of microarray data using Venn diagrams. To elimi-
nate the insignificantly (<2 fold) expressed genes, (i)t h e
subset of significant THP-1-CAM genes (784) was
cross-matched to the THP-1+CAM whole gene sum-
mary list (>0 fold) of 2584 genes and, (ii)t h es u b s e to f
significant THP-1+CAM genes (901) was cross-matched
to the THP-1-CAM whole gene summary list (>0 fold)
of 2557 genes. This cross comparison identified 28
genes in the THP-1-CAM subset and 35 genes in the
THP-1+CAM subset that were significantly changed (≥2
fold) between the two microarray conditions. The over-
lapping genes from these two data sets were pooled
(27 genes) and uniquely expressed genes in the -CAM
(1 gene) and +CAM (8 genes) were identified. Compar-
ing the results from these two gene subsets provided us
w i t hal i s to f3 6c a n d i d a t eh o s tc e l lg e n e sw h o s e
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ted (-CAM) and CAM treated (+CAM) arrays, indicat-
ing genes whose expression is modulated by de novo
synthesized C. burnetii proteins.
Host cell biological functions associated with THP-1
mRNAs modulated by de novo C. burnetii protein
synthesis
To determine the host cell biological pathways being
affected by C. burnetii protein synthesis, IPA was used.
Analysis of the subset of thirty-six differentially expressed
host genes modulated by C. burnetii protein(s) were clas-
sified according to the biological function they are asso-
ciated with, the protein’s cellular location, and its
molecular function (Table 1). A majority of the proteins
in this data set are predicted to reside in the cytoplasm
(14 proteins) and cell nucleus (9 proteins). Six proteins
are predicted to function in the extracellular space while
four proteins are thought to be located on the plasma
membrane. Other than cellular location, the host genes
Figure 3 Venn diagram of differentially expressed THP-1 genes. A venn diagram visualization showing 784 and 901 differentially expressed
host genes in C. burnetii infected THP-1 cells under mock (- CAM) and CAM treated (+ CAM) conditions respectively, as determined by oligonucleotide
microarray analysis. Comparisons between differentially expressed genes of -CAM with the gene summary list of + CAM (>0 fold Δ = 2584 genes) and
differentially expressed genes of + CAM with the gene summary list of -CAM (>0 fold Δ = 2557 genes) are also shown. The intersections (areas of
overlap) indicate genes regulated in common under both conditions. Twenty-eight of the differentially expressed genes in - CAM and thirty-five of the
differentially expressed genes in + CAM are modulated by C. burnetii protein synthesis (>2 fold difference). Of these, twenty-seven are common
between the two conditions, while eight and one genes are uniquely expressed in +CAM and -CAM conditions, respectively.
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tein’s function - i.e. enzyme, cytokine, transporter, tran-
scriptional regulator, or other. For the thirty-six gene
subset, Table 1 also lists the fold change found within the
separate mock treated and CAM treated microarrays,
respectively, as well as the fold difference between the
arrays. C. burnetii infected host cells had lower RNA
levels of twenty-two host genes relative to cells contain-
ing C. burnetii transiently inhibited with CAM. RNA
levels of fourteen genes in this data set are found to be
higher due to C. burnetii infection when compared to the
CAM treated condition. Bioinformatic analysis con-
ducted to determine possible biological functions of
these C. burnetii modulated host genes indicates that
immune response and cellular movement, cellular signal-
ing, cellular proliferation, cell death, lipid metabolism,
molecular transport, as well as vesicle trafficking, and
cytoskeletal organization are affected by C. burnetii pro-
tein synthesis (Table 1). These data indicate that the
expression of vital genes involved in cellular movement -
IL8, CCL2, CXCL1, SPP1 (cytokines) are suppressed via
C. burnetii’s protein synthesis in mock treated conditions
Table 1 Differentially expressed host genes modulated by C. burnetii protein synthesis




CTSB Cytoplasm peptidase 3.102 6.565 ↑3.463
Apoptosis CTSL1 Cytoplasm peptidase 3.173 6.914 ↑3.741
BCL3 Nucleus transcription regulator 3.103 5.673 ↑2.57
C11ORF82 Cytoplasm other -1.849 -4.912 ↓3.062
Cell proliferation SOX11 Nucleus transcription regulator 3.127 -2.915 ↓6.042
HELLS Nucleus enzyme -1.551 -4.653 ↓3.101
PGR Nucleus ligand-depend. nuclear recept. -1.539 -6.853 ↓5.313
ITK Cytoplasm kinase 2.752 -2.46 ↓5.212
Cell signaling DUSP9 Nucleus phosphatase -2.04 -4.388 ↓2.348
SKP2 Nucleus other 1.581 -2.627 ↓4.208
MTSS1 Cytoplasm other 4.389 6.986 ↑2.597
Cytoskeleton ANLN Cytoplasm other -1.943 -4.679 ↓2.735
SMTN Extracell. space other -3.319 4.006 ↑7.325
PLEKHO1 Plasma memb. other 2.162 5.396 ↑3.234
SPP1 Extracell. space cytokine 3.351 6.733 ↑3.382
Immune response CCL2 Extracell. space cytokine 5.053 7.451 ↑2.398
CXCL1 Extracell. space cytokine 5.221 7.275 ↑2.054
IL8 Extracell. space cytokine 7.839 9.985 ↑2.146
FABP4 Cytoplasm transporter 2.351 4.506 ↑2.155
Lipid metabolism APOE Extracell. space transporter 2.591 4.958 ↑2.367
PLIN2 Plasma memb. other 3.725 5.772 ↑2.047
RAB20 Cytoplasm enzyme 2.489 4.925 ↑2.436
FAM177B Unknown other 5.064 7.125 ↑2.061
SELM Cytoplasm other -2.23 2.531 ↑4.761
PSMA8 Cytoplasm peptidase -2.494 3.212 ↑5.706
MSC Cytoplasm transcription regulator 3.17 5.49 ↑2.32
MRPL44 Cytoplasm enzyme 2.775 -1.356 ↓4.131
Miscelleaneous CHMP5 Cytoplasm other 1.525 -2.189 ↓3.714
RORA Nucleus ligand-depend. nuclear recept. -6.756 7.147 ↑13.903
ZFP36L1 Nucleus transcription regulator 3.815 6.842 ↑3.027
ZNF573 Nucleus other 1.412 -3.322 ↓4.734
SLC22A6 Plasma memb. transporter 2.097 -2.146 ↓4.243
CDH2 Plasma memb. other -1.626 -3.634 ↓2.007
KIAA1279 Unknown enzyme 7.811 12.888 ↑5.077
SPATA6 Unknown other -2.473 19.906 ↑22.379
PSD4 Unknown other 2.197 -2.149 ↓4.346
1Fold change of expressed THP-1 genes in response to C. burnetii infection under mock treated condition.
2Fold change of expressed THP-1 genes in response to C. burnetii infection under CAM treated condition.
3Fold change difference increase (↑) or decrease (↓) between
1 and
2.
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tory molecules (IL8, CCL2, CXCL1, SPP1) regulate the
infiltration and trafficking of immune cells. Table 1
shows other crucial host genes specifically suppressed by
C. burnetii protein synthesis in THP-1 infection such as
BCL3, CTSB and CTSL1 (apoptosis), MTSS1, SMTN and
PLEKHO1 (cytoskeleton organization), APOE, PLIN2
and FABP4 (lipid metabolism), and RAB20, SOD2,
PSMA8, MSC, ZFP36L1, and RORA (Miscellaneous).
The prominent genes found to be up-regulated (induced)
due to C. burnetii’s protein synthesis are ITK, DUSP9 &
SKP2 (intracellular signaling), SOX11, HELLS & PGR
(cell growth and proliferation) SLC22A6, CDH2, PSD4,
ZNF573, CHMP5 & MRPL44 (Miscellaneous) and
ANLN (cytoskeleton organization).
RT-q PCR analysis of THP-1 gene expression in response
to mock and CAM treated C. burnetii infection
RT-qPCR was used to validate the expression trends of
selected genes identified by microarray analysis. Using
the same total RNA samples utilized for the microarray
hybridizations, six host genes were selected (IL8, CCL2,
ZFP36L1, APOE, RND3, and POU4F2) and analyzed by
RT-qPCR using the constitutively expressed b-actin gene
as a comparative control. In each case, the RT-qPCR data
matched the trends from the microarray analysis with
respect to whether expression was increased, decreased,
or unchanged. Figure 4 shows the fold expression differ-
ences of IL8, CCL2, ZFP36L1, APOE, RND3, and
POU4F2 identified by microarray in mock and CAM
treated experimental conditions (Figure 4A) and the sub-
sequent RT-qPCR analysis ( F i g u r e4 B ) .I L 8 ,C C L 2 ,
APOE, and ZFP36L1 represent genes that are increased
in mock treated C. burnetii infected THP-1 cells but
increase further when C. burnetii’s protein synthesis is
transiently inhibited using bacteriostatic levels of CAM.
The POU4F2 gene expression is decreased similarly
under both conditions and represents a THP-1 gene
modulated by C. burnetii infection whether or not active
protein synthesis is occurring. RND3 expression
increases similarly in C. burnetii infected THP-1 cells
regardless of ongoing bacterial protein synthesis. These
results confirm that genes with significant mRNA expres-
sion changes by oligonucleotide microarrays analysis are
differentially expressed when measured by RT-qPCR.
Discussion
Bacterial effector proteins are crucial to the survival and
growth of intracellular pathogens within the eukaryotic
cellular environment. These interactions may be at a myr-
iad of pathways or at points within a single pathway.
Moreover, the growth of C. burnetii within the lumen of
the PV would require the mediation of interactions with
the host cell using effector proteins, which are predicted
to be delivered by the pathogen’s type IV secretion system
[10,11,19]. The goal of this study was to identify host
genes that are specifically manipulated by C. burnetii pro-
teins. Our hypothesis was that the expression of host cell
genes will be changed by infection with C. burnetii NMII
and that the expression of a subset of these genes will be
directly affected by ongoing bacterial protein synthesis.
Identification of such genes will aid in the understanding
of host molecular mechanisms being targeted by C. burne-
tii during growth. In order to identify the host genes regu-
lated by C. burnetii proteins, we compared CAM and
mock treated mRNA profiles of THP-1 cells following a
72 h infection with C. burnetii. Microarray data analysis
shows that the majority of host genes were up- or down
regulated similarly in both the mock and CAM treated
array sets, suggesting that most THP-1 genes were not dif-
ferentially modulated at the RNA level by active C. burne-
tii protein synthesis. We had predicted that the majority
of expression changes in the host cell would be in
response to the physical presence of bacteria within the
cell. Using stringent analysis conditions, the transcriptional
response data comparisons identified thirty-six differen-
tially expressed genes, which were uniquely modulated by
C. burnetii proteins. The targeting of these host genes by
the pathogen indicates they may fall within pathways that
C. burnetii needs to modulate for its own survival.
During infection C. burnetii replicates intracellularly,
which aids in avoidance of the host immune response.
Immune clearance of bacteria is largely dependent on cel-
lular sensors called pattern recognition receptors (PRR)
found on phagocytes [36]. Activated macrophages then
eliminate bacteria through extrinsic or intrinsic apoptosis
and/or inducing pro-inflammatory cytokines [36]. Bacteria
employ indirect mechanisms to regulate cytokine produc-
tion by interfering with the NFkappaB signaling pathway,
which is a potent transcriptional activator of cytokines
[37]. Interestingly, of the thirty-six host genes that met our
criteria (Table 1) for C. burnetii protein driven expression
changes, four are cytokines (IL8, CCL2, CXCL1 and
SPP1). These secretory molecules are noted for chemo-
attraction of phagocytic and lymphocytic cells [38-40]. C.
burnetii protein(s) appear to reduce the RNA levels of
each of these four genes in infected THP-1 cells relative to
those found in infected cells transiently inhibited with
CAM. The ability of C. burnetii to avoid or suppress host
cytokine signaling, even transiently, may well represent an
essential part of its ability to survive and cause disease by
preventing communication between innate and adaptive
immune cells.
Although the control and clearance of C. burnetii
infection is T-cell dependent, specific data on T-cell
activation signals are lacking [4]. One study indicated
that an in vitro stimulation of peripheral blood mono-
nuclear cells (PBMC) by virulent and avirulent
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CCL2 [41]. Using a 36 h model of C. burnetii infection,
a DNA microarray study reported an increase in host
cell expression of certain chemokines (RANTES,
SCYA3, SCYA4, and IL8). The study also observed no
induction of TNF-a and IL-1b after 36 h of infection,
but the antimicrobial response gene encoding cyto-
chrome b-245 (CYBB) was up-regulated [28]. In the cur-
rent study, IL8 gene expression was also increased due
to C. burnetii infection but expression was further
increased when C. burnetii protein synthesis was inhib-
ited, suggesting that bacterial protein(s) differentially
modulate the expression of IL-8 during infection. In
addition, the IL8 receptor gene (IL8RB) was found to be
down regulated in mock treated, infected THP-1 cells
(see Additional file 1- Table S1.A). This is the first evi-
dence of host cell cytokine production being modulated
by C. burnetii protein during an infection.
In addition to the immune response, C. burnetii has to
overcome another central host defense mechanism, apop-
tosis. The intracellular pathogens C. trachomatis, Myco-
bacterium tuberculosis as well as C. burnetii posses
mechanisms to subvert cell death pathways [13,14,42,43].
C. burnetii has been shown to inhibit host cell apoptosis by
a mechanism that prevents cytochrome C release from the
mitochondria [13]. C. burnetii directs the sustained activa-
tion of host pro-survival kinases Akt and Erk1/2, which are
necessary for anti-apoptotic activity [13,14]. Table 1 shows
that seven of the thirty-six C. burnetii protein modulated
THP-1 genes are associated with apoptosis and cell prolif-
eration within eukaryotic cells. C. burnetii protein(s) sup-
press the expression of three genes (BCL3, CTSB, and
CTSL1), when compared to expression levels present in
CAM treated THP-1 cells, which can have pro-apoptotic
activities. By modulating these host genes during infection
C. burnetii appears to promote its own survival by
Figure 4 RT-qPCR of selected genes confirms microarray expression trends. A, shows the microarray data of the genes used to confirm
microarray expression trends. Fold difference (-CAM) is the fold change of differentially expressed THP-1 genes in response to C. burnetii
infection after mock treatment. Fold difference (+CAM) is the fold change of differentially expressed THP-1 genes in response to C. burnetii
infection after CAM treatment. B, difference in mRNA levels in selected genes relative to b-actin. An equal amount of total RNA from each
sample was analyzed by RT-qPCR. The Y-axis represents fold changes in gene expression while X axis shows the conditions under which gene
expression was observed (mock and CAM treated, and uninfected and C. burnetii infected THP-1 cells). U-CAM, uninfected THP-1 minus CAM. U
+CAM, uninfected THP-1 plus CAM. I-CAM, infected THP-1 minus CAM. I+CAM, infected THP-1 plus CAM. The results represent the mean of three
biological samples and three technical replicates of each sample. Error bars represent the s.e.m.
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four cell proliferation/survival genes (C11ORF82, PGR,
SOX11 and HELLS) are significantly reduced when C. bur-
netii’s protein synthesis is inhibited during infection of
THP-1 cells (Table 1). The expression of each of these
genes is higher in infected cells than in infected cells where
bacterial protein synthesis is inhibited, again indicating
that C. burnetii protein(s) have an anti-cell death affect.
Interestingly, our microarray analysis also shows a 4-fold
expression decrease of TNFRSF10A (Death receptor 4) in
mock treated infections of THP-1 cells (Additional file 1-
Table S1.A). Normally, TNFRSF10A induces apoptosis by
binding to TNFSF10/TRAIL ligand in cells [44], suggesting
that the expression changes in C. burnetii infected cells
may represent another means of inhibiting host cell death.
Eukaryotic host cell cytoskeleton (actin filaments,
microtubules and intermediate filaments) are a common
target of molecular interactions for intracellular micro-
bial pathogens [9]. Virulent C. burnetii has been shown
to affect F-actin reorganization in THP-1 cells [45,46].
F-actin has also been shown to be associated with PV
formation and homotypic fusion of C. burnetii contain-
ing vacuoles, although PVs are able to acquire lysosomal
markers when F-actin formation is inhibited [47]. Our
analysis indicates that MTSS1, ANLN, SMTN and PLE-
KHO1 are differentially modulated by C. burnetii pro-
tein synthesis (Table 1). Compared to CAM treated
THP-1 infections, the relative expression levels of
MTSS1, SMTN and PLEKHO1 is lower in THP-1 mock
treated infections. The relative expression of ANLN is
higher in mock treated C. burnetii infections than in
CAM treated infections. Interestingly, ANLN interacts
with F-actin and is over expressed in dividing cells [48],
suggesting that C. burnetii infection supports cell
growth and division. The structure and integrity of the
PV as well as host cell vesicles fusogenicity with the PV
is dependent on cytoskeletol structures [47]. Finding
that four out of the thirty-six genes are associated with
the regulation and function of the cells cytoskeleton
supports findings that the cytoskeleton is crucial to C.
burnetii during infection.
Manipulation of cellular lipids is emerging as an
important factor in infectious diseases [49,50]. Host cell
cholesterol levels affect the growth of intracellular bac-
terial pathogens such as Salmonellae, Mycobacteriae,
Brucellae, Anaplasma,a n dCoxiellae [12,50]. Little is
known about cholesterol levels or imbalance in Q-fever
patients, but studies at the cellular level indicate that C.
burnetii infected Vero cells contain 73% more choles-
terol than uninfected cells [12]. Table 1 lists three C.
burnetii protein(s) modulated host genes (APOE, PLIN2,
and FABP4) that are associated with lipid metabolism
and regulation. These genes have lower relative expres-
sion levels in the mock treated THP-1 infections when
compared to the CAM treated THP-1 infections. APOE
is a multifunctional protein primarily involved in choles-
terol homeostasis [51-55]. Endogenously, APOE pro-
motes cholesterol efflux in macrophages to lower
intracellular cholesterol concentrations. Macrophages
deficient in APOE are severely compromised in choles-
terol homeostasis [51-55]. PLIN2 and Fatty acid binding
protein 4 (FABP4) are proteins that associate with lipids
and fatty acids, respectively, and mediate the stabiliza-
tion of lipid droplets and fatty acid transport [56,57]. An
increase in cholesterol regulating proteins would be
expected in response to the profound increases in the
cellular concentration of cholesterol seen during C. bur-
netii infection. This makes the increase in APOE expres-
sion observed upon inhibition of C. burnetii protein
synthesis particularly noteworthy. It seems that modula-
tion of these key lipid homeostasis genes allows C. bur-
netii to not only suppress the loss of host cell
cholesterol but to also direct lipid trafficking.
Bacterial pathogens often subvert host cell signaling
pathways by introducing bacterial effector proteins that
interfere with host cell phophorylation cascades [9].
C. burnetii dependent regulation of host cell signal
transduction pathways are not well understood. Our
data identified active modulation of three host cell signal
transduction genes (ITK, DUSP9 and SKP2) by C. bur-
netii’s protein(s). While ITK and SKP2 play significant
roles in inducing host cell proliferation [58,59], DUSP9
is a mitogen-activated protein kinase phosphatase
(MKP) that negatively regulates MAPK activity in mam-
malian cells, thus preserving the cell from apoptosis
[60]. The expression of these genes are relatively higher
in C. burnetii infected THP-1 cells compared to the
expression levels found in C. burnetii infected THP-1
cells transiently inhibited by CAM. This suggests that
C. burnetii protein synthesis “encourages” cell prolifera-
tion in addition to its anti-apoptotic effects as a means
to preserve the host cell environment.
In addition to the outlined host cell processes, we
identified a variety of genes involved in diverse functions
of a host cell, which were also modulated by C. burnetii
protein synthesis (Table 1). In this miscellaneous cellular
functions category, some genes were expressed at rela-
tively higher levels than what was expressed in CAM
inhibited infected cells and are of particular interest.
The PSD4 gene, which is involved in membrane recy-
cling [61], and CHMP5, which is an essential regulator
of late endosome function. CHMP5 null cells show
enhanced signal transduction, protein accumulation in
enlarged multi vesicular bodies (MVB) and inhibition of
MVB trafficking to lysosomes [62]. In addition, we have
recently found that markers of multi lamellar/multi vesi-
cular bodies associate with membrane structures within
the PV lumen during C. burnetii infection of Vero cells
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replication niche possesses markers consistent with
those on late endosomes/lysosomes [2], our finding that
expression of these genes are markedly lower when C.
burnetii protein synthesis is inhibited suggests that they
play a part in development and maintenance of the PV
during infection. This overall manipulation of endocyto-
sis, vesicle trafficking, and late endosome/lysosome
maturation is in agreement with studies which found
that inhibition of C. burnetii protein synthesis at any
point during the life cycle changes these processes
within C. burnetii infected cells [35,63].
Conclusions
Through this study we have discovered thirty-six host
cell genes with significant relative expression changes
after transient inhibition of C. burnetii protein synthesis.
The expression changes of these genes in the mock and
CAM treatment conditions were confirmed using RT-
qPCR analysis. Using bioinformatics, we have also deter-
mined the predominant host cell processes associated
with these genes. Collectively, these data support our
hypothesis that C. burnetii proteins differentially modu-
late host cell genes during infection. Predominant cellu-
lar functions that are modulated by C. burnetii proteins
include (i) innate immune response, (ii) cell death and
proliferation, (iii) vesicle trafficking and development,
(iv) lipid homeostasis, and (v) cytoskeletal function.
These findings indicate that C. burnetii actively modu-
lates the expression of genes that may play a role in the
ability of the pathogen to establish the PV, survive, and
replicate within the intracellular environment.
Additional material
Additional file 1: Tables S1.A-I. Excel file containing Tables S1.A
through S1.I as individual tab-accessible tables within a single file
(Supplemental Table S1.A-I).
Additional file 2: Figure S1. Biological function assignments of
genes differentially expressed in mock and CAM treated THP-1 cells
infected with C. burnetii. Both sets of microarray data (Additional file 1-
Supplemental Tables S1.A and S1.B) containing differentially expressed
genes for mock and CAM treated C. burnetii infections of THP-1 cells
were annotated using DAVID to extract the biological functions of the
listed genes. The X axis shows the percentage of differentially expressed
genes associated with each annotation term while the Y axis shows the
prominent biological functions (annotation terms) obtained through
functional annotation of the differentially expressed genes. P-values for
each annotation term are calculated using modified Fisher’s exact test. A
P-value cut off 0.05 or less has been used to identify biological functions.
Top panel, shows the common host cell functions regulated under both
conditions (mock and CAM treatment). Middle panel shows the major
cellular functions affected only in C. burnetii infected THP-1 cells
undergoing mock treatment. Bottom panel shows the crucial host cell
functions influenced only in C. burnetii infected THP-1 cells undergoing
CAM treatment.
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